Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Phentolamine Mesilate

    • Product Name Phentolamine Mesilate
    • Alias Regitin
    • Einecs 242-225-7
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    263054

    Generic Name Phentolamine Mesilate
    Drug Class Alpha-adrenergic antagonist
    Molecular Formula C17H19N3O · CH4O3S
    Indications Treatment of hypertensive emergencies, diagnosis of pheochromocytoma, prevention and treatment of dermal necrosis after extravasation of norepinephrine
    Mechanism Of Action Blocks alpha-1 and alpha-2 adrenergic receptors, causing vasodilation
    Route Of Administration Intravenous, intramuscular
    Onset Of Action Rapid (within 2 minutes when given IV)
    Duration Of Action Short (about 10-15 minutes)
    Contraindications Known hypersensitivity, recent myocardial infarction, coronary artery disease
    Side Effects Tachycardia, arrhythmias, hypotension, flushing, nasal congestion

    As an accredited Phentolamine Mesilate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for Phentolamine Mesilate features a white box labeled "Phentolamine Mesilate 50 mg," containing 10 sterile ampoules.
    Shipping Phentolamine Mesilate is shipped in tightly sealed, clearly labeled containers, compliant with chemical safety regulations. It is protected from moisture, light, and extreme temperatures. Packages include safety data sheets (SDS) and hazard labels. Transportation follows guidelines for hazardous pharmaceuticals, ensuring secure, upright, and temperature-controlled delivery to the destination.
    Storage Phentolamine Mesilate should be stored in a tightly closed container at room temperature, typically between 15°C and 30°C (59°F to 86°F), and protected from light and moisture. It should be kept away from incompatible substances and out of reach of children. Avoid exposure to excessive heat or direct sunlight to maintain its stability and efficacy.
    Application of Phentolamine Mesilate

    Applications of Phentolamine Mesilate in Industrial Manufacturing

    Phentolamine Mesilate finds established usage across a concentrated set of specialized industrial and pharmaceutical manufacturing fields, owing to its distinct alpha-adrenergic blocking properties and regulatory recognition. As a direct manufacturer, we supply this active ingredient to certified downstream producers who integrate it using rigorous quality management and compliance systems. The following sections outline practical scenarios where our product forms an essential part of the end-user value chain.

    1. Injectable Pharmaceutical Formulations for Hypertensive Crisis Management

    Global large-volume parenteral manufacturers utilize Phentolamine Mesilate in hospital-use injections designed for rapid blood pressure reduction during hypertensive emergencies or control of catecholamine-induced hypertensive episodes. In these applications, the ingredient must conform to stringent injectable grade requirements and pharmacopoeia standards. Bulk active material undergoes strict incoming QC, and is dissolved directly in sterile, pyrogen-free water during compounding, followed by immediate sterile filtration and aseptic filling. Typical end products target institutional treatment protocols for critical care.

    Industry compliance standards

    • USP/EP/JP/CP injectable monographs
    • GMP for Sterile APIs (ICH Q7, PIC/S, EMA, US FDA CFR 21 Part 211)
    • EU EudraLex Volume 4 for parenterals
    • DMF (Drug Master File) reference acceptance

    Typical usage ratio

    • 1mg to 10mg per unit dose (ampoules or vials), batch formula typically 0.01–0.1% w/v; final concentration adjusted based on target clinical application and stability data

    Downstream process integration

    • Dissolution into sterile compounding solution after incoming identity and purity confirmation, then sterile filtration and direct aseptic filling into glass ampoules or vials

    Final product types

    • Hospital-use injectable solutions (glass ampoules, vials) for acute hypertensive management and diagnostic procedures

    2. Oral Tablet Production for Pheochromocytoma Preoperative Control

    Solid oral dose manufacturers integrate Phentolamine Mesilate into uncoated or film-coated tablet production lines targeting the management of specific rare endocrine tumors, such as pheochromocytoma, to block hypertensive surges preoperatively. Formulators rely on regulatory documentation, such as CEPs and stability reports, to justify inclusion in oral tablets. Raw material enters via direct dry blending with excipients, followed by high-shear granulation, compression, optional film-coating, and GMP-controlled packaging.

    Industry compliance standards

    • Pharmacopoeial standards (USP, EP, JP)
    • GMP for solid dosage forms (FDA, WHO TRS 986 Annex 2, EU Guidelines Volume 4)
    • Relevant national pharmacovigilance and batch release requirements
    • ICH Q1A(R2) for stability

    Typical usage ratio

    • Varies per country and indication; commonly 10–60mg per tablet, accounting for approximately 1–4% by weight in final blend depending on potency and formulation excipients

    Downstream process integration

    • Weighing and direct blending into core tablet formulation, granulation and compression, with post-blending in closed systems to limit cross-contamination

    Final product types

    • Pheochromocytoma preoperative oral tablets (blister packs, bulk bottles) supplied to hospital and specialty pharmacy channels

    3. Compounded Hospital Pharmacy Preparations (Extemporaneous Solutions)

    Pharmacies in major medical centers depend on Phentolamine Mesilate as a critical API to prepare individualized, extemporaneously compounded solutions for neonates and pediatric patients with pharmaceutical intolerance to commercial ready-made alternatives. Here, the API is supplied with detailed CoAs and meets specific endotoxin and impurity thresholds. It enters the hospital compounding workflow by reconstitution with pharmacy-grade sterile water, followed by aliquoting, labeling, and tracked dispensing.

    Industry compliance standards

    • USP <795> (Pharmaceutical Compounding–Nonsterile Preparations)
    • USP <797> (Pharmaceutical Compounding–Sterile Preparations)
    • USP/NF for API monographs
    • National regulatory controls for hospital pharmacy compounding

    Typical usage ratio

    • 100 microgram/mL to 1mg/mL in reconstituted solution; final strength tailored per prescription and clinical requirements, always compounded per batch/tray under pharmacist control

    Downstream process integration

    • Direct weighing and dissolution for small-batch hospital pharmacy preparation, with filtering and manual aliquoting into pre-sterilized administration syringes

    Final product types

    • Patient-specific compounded injection solutions, syringes, or intravenous admixtures dispensed for critical care or pediatric dosing

    4. Diagnostic Reagent Kit Manufacturing for Sympathetic Nervous System Testing

    Specialty reagent kit manufacturers incorporate our API to create in vitro diagnostic kits for provocative testing of sympathetic nervous system function, such as in differentiation of vascular dysfunction. Phentolamine Mesilate is standardized to meet analytical grade purity thresholds and is introduced following dry mixing with stabilizers, later filled into sealed reagent vials for clinical laboratory use. These kits include all necessary quality traceability and support calibration for laboratory assays.

    Industry compliance standards

    • ISO 13485 (Medical Devices–Quality Management for IVD Reagents)
    • FDA 21 CFR 820 (Quality System Regulation for IVDs)
    • EU IVDR (Regulation (EU) 2017/746) where applicable
    • Analytical reference standards for in vitro diagnostics

    Typical usage ratio

    • 0.5mg to 2mg per assay vial, custom-blended within a final formulation of 0.01–1% by weight after analytical method validation

    Downstream process integration

    • Direct entry into reagent blending system, followed by analytical-scale filling and lyophilization or sealing into single-use laboratory vials under cleanroom conditions

    Final product types

    • Clinical diagnostic reagent kits for vascular function testing (laboratory use only)
    Free Quote

    Competitive Phentolamine Mesilate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Phentolamine Mesilate: Consistent Quality Starts at the Source

    Introducing Phentolamine Mesilate from the Manufacturer's Perspective

    Phentolamine mesilate isn’t just another active pharmaceutical ingredient sitting on a generic product list. It carries a legacy in the healthcare world, trusted by hospitals, compounding pharmacies, and research teams who rely on an authentic, stable supply. Our plant has focused on this compound for years, responding to real questions from pharmacologists and scientists — not just brokers or distributors. From the start, our engineers got familiar with the tiny shifts in crystal structure, the flow properties of each batch, and the chemistry that makes real clinical difference. It changes the way hospitals treat hypertensive crises and supports researchers who investigate vascular disorders. Every bottle tells a story of direct involvement, hands-on improvements, and a single-minded focus on what matters to end users.

    Quality and Reliability at Each Stage

    You measure reliability in healthcare chemistry with the raw numbers: purity, moisture, crystalline form, and batch repeatability. Our technical team watches every stage, from synthesis in reaction vessels, through carefully monitored recrystallization, to the last drying cycle. We don’t chase unpredictable shortcuts or swap solvents mid-stream, knowing how much hospital supply chains dislike performance hiccups. Precision determines how the mesilate salt responds to reconstitution, syringeability, and the end-user’s mixing process at the bench. We send out every batch with documentation that makes sense to real-life scientists—reflecting what’s inside the bottle, not a marketing promise.

    Model, Specifications, and Customization

    Medicinal chemists and compounders value predictability — we learned this from conversations with hospital pharmacists and academic researchers over years. Our phentolamine mesilate meets high standards for particle size and uniformity. Most lots reach particle diameters between 40 to 60 microns, aimed at helping solutions dissolve quickly and evenly. Melting point, moisture levels, and residual solvents reflect the solvent pathway selected for each synth run. Models or “grades” in our own catalog follow clinical expectations, with options for injectable grade or research grade as determined by how they’ll get handled downstream. Each specification responds to issues flagged by practitioners: dustiness in cleanrooms, variable dissolution times, or interference in downstream analytics.

    Using Phentolamine Mesilate in Clinical and Research Work

    In current clinical settings, phentolamine mesilate appears most often as an emergency vasodilator, counteracting hypertensive episodes and easing blood vessel constriction after procedures like surgery or accidental administration of vasopressors. Researchers, on the other hand, value it for the way it blocks alpha-adrenergic receptors, creating a clean slate for studying cardiovascular pathways or new drug combinations. Our plant’s technical support team keeps in touch with both fields. They bring questions from actual users back to manufacturing, instead of chasing abstract industry trends. Because we control every step of the phentolamine mesilate process, we help troubleshoot problems that pop up: cloudy solutions, unexpected sediment, or sensitivity to light or heat. Our batches show resilience to standard hospital prep routines, not just lab-bench conditions.

    Consistency Sets Manufacturer Supply Apart

    Traders and resellers move boxes, chasing unit price and margin. For manufacturers, consistent quality matters even when commodity markets shift. We hold inventory at the source, test every lot against a reference standard created in-house, and maintain qualified stability protocols. Pharmaceutical buyers can easily trace each batch. If a research scientist faces trouble during method validation or gets unexpected chromatogram peaks, our production notes track the lot history, process tweaks, and any observed trends. Sometimes clients ask about minor changes in color, particle feel, or handling during high-humidity stretches. We answer straightforwardly, relying on manufacturing logs and technician notes — not just a template report. This transparency builds confidence with end users who stake their work on more than just paperwork.

    What Makes Our Phentolamine Mesilate Different

    There are real differences between phentolamine mesilate from a direct manufacturer and one that’s passed through distributors or brokers. Control starts with the raw amines: reliable precursor selection, supported by contamination checks before the reaction ever runs. Here, purity isn’t something to audit at the end, but something tracked with every reaction drum, solvent, and filter change. Our process stays flexible enough to develop new grades or answer requests from clinical partners who need tighter tolerances or a specific crystal habit. Pharmacists rely on stable, dust-free powder. Clinical-grade lots run through additional sterilization and bioburden checks developed after real-world feedback flagged supply issues elsewhere. We don’t view upgrades as optional; they grow from conversations with healthcare professionals who expect more than basic compliance.

    Listening to Users: Addressing the Day-to-Day Demands

    Every query from a hospital pharmacy, a contract manufacturing partner, or a university lab matters to our team. We’ve worked through questions about bottle sizes, labeling contrast, and bulk packing to keep handling safer and faster on the ground, not just cheaper for shipment. Hospital technicians pressed us for less static cling; researchers requested specific lot numbers for smooth regulatory submissions. Our approach: blend practical field input with routine quality checks and investment in training new operators. That attitude goes beyond paperwork and right into the next batch, improving process flows, cleaning methods, and how we address out-of-spec feedback. Our team treats deviations not as headaches, but as opportunities to home in on what helps real users get dependable, reproducible outcomes.

    Compliance and Transparency Every Step of the Way

    We do not outsource quality management or regulatory documentation. All compliance comes straight from process-controlled steps at our own facility. Every certificate reflects both lab measurements and production records visible to regulatory surveyors. Stability testing for phentolamine mesilate runs on real samples, stored at hospital-relevant temperature ranges, and gets extended if partners need longer holding times. Audits are accepted as a routine part of the job. GMP and ISO frameworks guide our documentation, but practical experience means we spot trends early — such as possible cross-contamination or rare batch-to-batch variation — so intervention happens fast. Genuine transparency means making sure any changes, such as a batch improvement or packaging tweak, are clearly explained and documented.

    Supporting Reasonable Pricing Without Cutting Corners

    Long-term relationships come from trust and performance, not chasing cycles of price wars and margin cuts. We price our phentolamine mesilate for sustained partnership, reflecting the cost of direct manufacturing, traceable documentation, and technical support that doesn’t disappear after shipping. Supply agreements with major health networks or research clusters grew out of performance, not price competition. If costs shift on raw input, solvent, or labor, we work with partners to map out timetables and phase in adjustments smoothly. End-users stay informed, making their own procurement plans more predictable. We refuse to substitute lower-grade precursors or hastily reroute batches to hit a short-term quote; these shortcuts risk quality drift and client confidence. Our financial discipline supports not just our own operation, but the success and safety of the healthcare chain downstream.

    Science-Driven Innovation, Not Market-Driven Imitation

    Market trends shift but the clinical need for phentolamine mesilate remains rooted in its reliable action, solubility, and drug interaction profile. As the manufacturer, we invest in pilot runs that explore new crystallization methods, alternative forms, and process automation — always with input from scientists who rely on rapid dissolution, clear endpoint titration, or improved handling properties. Some researchers request custom packaging in oxygen-barrier film or ask for full trace-metal reports to support regulatory submission. These requests feed back into our R&D loop, making future lots match tighter specifications and support more ambitious trials. Instead of following a lowest-cost mentality, we prefer to build forward with method validation, innovation on process analytics, and data-sharing with research partners focused on new therapies or administration routes.

    Real-World Impact of Consistent Supply

    Healthcare teams experience acute risks if pharmaceutical-grade phentolamine mesilate supply falters. A missed emergency shipment delays key procedures, exposes hospitals to sudden procurement risks, and forces improvisation that undermines treatment plans. Our role goes far beyond product delivery — it’s about planning, buffering inventory, and supporting logistics partners to reach clinics on short lead times, even when global freight or customs shifts emerge. We keep open communication with buyers, flagging possible delays or supply pattern shifts, and respond with realistic solutions, such as holding pre-approved backup lots or preparing short-run resupply batches. District hospitals and clinical trial teams depend on this consistency in planning patient interventions; lives and data sets don’t wait for excuses about upstream market surprises.

    Experience Bred from Practice, Not Theory

    Teams on our production floor talk daily with batch lab staff and customer support. Many operators have seen phentolamine mesilate synthesis through different regulatory cycles, technology upgrades, and expansion periods. Fielding calls from hospitals that report clumping, color shifts, or questions about shelf life supplies direct feedback. Instead of reading customer support scripts, our staff roll up their sleeves, pull reference samples, or repeat analytical runs directly in the quality lab. On occasion, we even walk customers through troubleshooting live over video or by email, sharing measured findings and experience learned through practice, not just manuals. Such responsiveness builds both trust and professional pride, connecting manufacturing to the realities of patient care and real research environments.

    Investment in People, Process, and Future Readiness

    It takes more than well-maintained reactors and clean facilities to ensure long-term stability in phentolamine mesilate production. Our senior process engineers mentor each new technician, passing down maintenance routines, reaction timing intuition, and response protocols for outlier test results. Investing in equipment upgrades lets us reduce downtime, boost reliability, and tailor capacity to rising healthcare demand. We partner with technical colleges to train incoming staff and keep learning programs up-to-date with evolving standards and real feedback from the field. This focus on practical skill, not just theoretical compliance, sets up our team to handle unexpected challenges — from raw material shortages to regulatory changes or sudden global demand surges. Improvement becomes a mindset, not a checkbox, driven by both pride in the product and accountability to end-users.

    Sustainability and Responsible Practices

    Environmental responsibility forms a real part of our process, not just corporate reporting. Solvent choice, waste management, and energy usage have all changed over years of making phentolamine mesilate, adjusting as new regulations or internal audits demand more thoughtful stewardship. Investments in solvent recovery, emissions monitoring, and waste stream minimization benefit both the environment and operational safety. Our facility tracks its own usage and seeks reductions without undermining product quality, and we assemble safety teams to regularly review incident records and prevention strategies. By managing in-house, we bear direct responsibility for each improvement, not outsourcing tough decisions or passing risks to others down the supply chain. End-users expect reassurance that their supply comes free of hidden environmental risks, and we carry that trust into everyday practice at every step.

    Security and Supply Chain Resilience

    Security risks and raw material disruptions rarely make headlines, but any real manufacturer keeps a close eye on these pressures. Our procurement teams check the credentials and stability of every supplier — especially for key reagents and amines that go into phentolamine mesilate synthesis. We spread out sources, store safety stocks on-site, and coordinate alternative supplier plans for all critical materials. Risk isn’t theoretical: unpredictable border closures, power outages, or sudden commodity price swings have tested our readiness. By keeping a transparent communication channel open with downstream partners, we alert buyers early and coordinate necessary shifts in delivery timing or batch allocations. Our business style reflects operational reality, placing reliable supply and data integrity above short-term sales upticks.

    Open Collaboration with Researchers and Healthcare Professionals

    Leading manufacturing teams see the best improvements when partners share feedback and ask hard questions. We open doors to research groups, hospital procurement teams, and regulatory inspectors. Whether a partner needs extended data, stability studies in unusual climate zones, or custom geometry of packaging for dispensary automation, we tackle these requests by mixing design input with hands-on experimentation. Partnerships with academic researchers or innovators allow us to pilot new process tweaks — yielding results that feed back into the next standard operating procedure. These collaborations build more than just sales; they foster a knowledge exchange, where the underlying science improves alongside each round of production upgrades.

    Proactive Solutions for Professional Users

    Medical teams and scientific users bring unique problems that off-the-shelf distributors might overlook. We address these by keeping rapid-response teams, equipped to run reference tests, validate a new lot for a tender, or clarify a technical disagreement with auditors. Feedback is logged and shared internally, so that production teams learn about pain points before they impact reliability on a bigger scale. Instead of waiting for trends to become complaints, our staff meet quarterly to scan for outlier data or batch records showing deviation risks. We believe the real work of a manufacturer isn’t finished with shipment — it continues in the field, in partnership with those who depend on our work for solutions that work every time, not just most of the time.

    The Manufacturer's Commitment

    Phentolamine mesilate represents more than an item on a chemical list: it’s a commitment to scientific rigor, patient safety, and reliable supply. Years of production experience flow into every package, backed by continuous improvement, open communication, and practical expertise from every team member on the floor. We focus on building trust through proven performance, technical support rooted in firsthand knowledge, and responsive service that adapts to the changing landscape of healthcare. In the long run, what distinguishes our phentolamine mesilate is the depth of process control and the lived experience of making sure the next batch is as dependable as the last. Trust starts at the source — and our team stands behind every order, supporting the communities and professionals who rely on us for uncompromised quality and delivery.